Loading…
Nanobiotix S.A. is projected to rise to $54.77 by 2027, a +35% move from its current price of $40.50. NBTX is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $38.29 | $40.53 | $42.90 | +0.07% |
| May 30 | $37.42 | $40.56 | $43.95 | +0.14% |
| May 31 | $36.78 | $40.58 | $44.78 | +0.21% |
| Jun 1 | $36.25 | $40.61 | $45.50 | +0.28% |
| Jun 2 | $35.79 | $40.64 | $46.15 | +0.34% |
| Jun 3 | $35.38 | $40.67 | $46.74 | +0.41% |
| Jun 4 | $35.01 | $40.70 | $47.30 | +0.48% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $35.01 | $40.70 | $47.30 | +0.48% |
| Week 2 | $33.06 | $40.89 | $50.58 | +0.97% |
| Week 3 | $31.67 | $41.09 | $53.32 | +1.45% |
| Week 4 | $30.56 | $41.29 | $55.78 | +1.94% |
| Week 5 | $29.64 | $41.49 | $58.07 | +2.44% |
| Week 6 | $28.84 | $41.69 | $60.25 | +2.93% |
| Week 7 | $28.14 | $41.89 | $62.36 | +3.43% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Nanobiotix S.A. operates as a clinical-stage biotechnology that focuses on developing product candidates for the treatment of cancer and other unmet medical needs. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for the treatment of soft tissue sarcoma, head and neck, liver, prostate, pancreatic, esophageal, rectal, and non-small cell lung cancer.
The company has a partnership with Lian Oncology Limited to develop and commercialize NBTXR3 in China, South Korea, Singapore, and Thailand. Nanobiotix S.A. was incorporated in 2003 and is based in Paris, France.
Nanobiotix S.A. trades under the symbol NBTX and currently has a price of $41.01 with a market capitalization of $1.99B. The stock is ranked 2004 by market capitalization.
A major floor 55.9% below — a decisive break under it would weaken the trend.
The nearest floor, 24.0% below — buyers have tended to step in here.
The nearest ceiling, 36.0% above — a clean break opens room to run.
A major ceiling 63.9% above — clearing it would confirm fresh momentum.
Key NBTX support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of NBTX market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $41.13 | Sell | $41.90 | Sell |
| MA 10 | $45.99 | Sell | $43.25 | Sell |
| MA 20 | $43.02 | Sell | $42.30 | Sell |
| MA 50 | $36.21 | Buy | $37.69 | Buy |
| MA 100 | $30.80 | Buy | $32.56 | Buy |
| MA 200 | $24.27 | Buy | $25.82 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 48.98 | Neutral |
| Stoch RSI (14) | 1.29 | Buy |
| CCI (20) | -29.15 | Neutral |
| Williams %R (14) | -97.85 | Info |
| MACD (12,26,9) | -1.24 | Sell |
| ROC (12) | -10.97 | Sell |
| Bollinger %B (20,2) | 0.41 | Neutral |
| Stochastic %K (14) | 2.15 | Buy |
| TRIX (15) | 1.34 | Buy |
| Awesome (5,34) | 2.51 | Buy |
| Ultimate (7,14,28) | 25.58 | Buy |
| Momentum (10) | -7.74 | Sell |
| Aroon Osc (25) | 68.00 | Buy |
| Hull MA (9) | 38.24 | Buy |
| ADX (14) | 16.93 | Neutral |
| ATR (14) | 2.28 | Info |
The 30-day technical picture is bullish. RSI14 is 50, and the price action is supported by a 50-day simple moving average of $35.92 and a 200-day simple moving average of $23.94.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $19.97 | $40.50 | $59.12 | 0% | Neutral | |
| $39.41 | $54.77 | $82.36 | +35% | Bullish | |
| $38.30 | $56.48 | $90.28 | +39% | Bullish | |
| $39.12 | $60.73 | $101.78 | +50% | Bullish | |
| $48.15 | $78.32 | $136.53 | +93% | Bullish | |
| $53.50 | $90.92 | $163.99 | +125% | Bullish | |
| $74.75 | $132.48 | $246.27 | +227% | Bullish | |
| $88.02 | $162.43 | $310.24 | +301% | Bullish | |
| $75.39 | $144.70 | $283.29 | +257% | Bullish | |
| $78.23 | $156.07 | $312.58 | +285% | Bullish | |
| $142.67 | $317.04 | $697.35 | +683% | Bullish | |
| $220.65 | $490.33 | $1,127.75 | +11.1x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $19.97 | $40.50 | $48.48 | +0.00% |
| June 2026 | $36.16 | $43.37 | $53.90 | +7.09% |
| July 2026 | $35.35 | $43.12 | $54.96 | -0.58% |
| August 2026 | $34.55 | $42.70 | $55.49 | -0.97% |
| September 2026 | $36.07 | $45.08 | $59.49 | +5.56% |
| October 2026 | $36.38 | $45.93 | $61.47 | +1.89% |
| November 2026 | $34.17 | $43.54 | $58.97 | -5.22% |
| December 2026 | $33.57 | $43.15 | $59.12 | -0.88% |
Click any year to see its month-by-month NBTX forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, NBTX is projected to trade between $19.97 and $59.12, averaging $40.50 — a potential gain of 0% from today's $40.50. A consolidation phase looks the most probable path here.
Nanobiotix S.A.'s 2027 outlook centres on $54.77, within a $39.41 to $82.36 range. That is up +35% on the projected 2026 average. That marks a +35% change versus current levels. Momentum favours further upside here.
By 2028, NBTX could reach as high as $90.28, with a base case around $56.48 and support toward $38.30 — roughly +39% from $40.50. Buyers look set to stay in control over this stretch.
Expect NBTX to range from $39.12 to $101.78 through 2029. The $60.73 average target implies a +50% move from current prices. That is up +8% on the projected 2028 average. Momentum favours further upside here.
The NBTX price prediction for 2030 points to an average of $78.32 (low $48.15, high $136.53) — a potential gain of +93% on today's $40.50. Buyers look set to stay in control over this stretch.
In 2031, NBTX is projected to trade between $53.50 and $163.99, averaging $90.92 — a potential gain of +125% from today's $40.50. That is up +16% on the projected 2030 average. Momentum favours further upside here.
Nanobiotix S.A.'s 2032 outlook centres on $132.48, within a $74.75 to $246.27 range. That is up +46% on the projected 2031 average. That marks a +227% change versus current levels. Buyers look set to stay in control over this stretch.
By 2033, NBTX could reach as high as $310.24, with a base case around $162.43 and support toward $88.02 — roughly +301% from $40.50. Momentum favours further upside here.
Expect NBTX to range from $75.39 to $283.29 through 2034. The $144.70 average target implies a +257% move from current prices. That is -11% versus the projected 2033 average. Buyers look set to stay in control over this stretch.
The NBTX price prediction for 2035 points to an average of $156.07 (low $78.23, high $312.58) — a potential gain of +285% on today's $40.50. Momentum favours further upside here.
In 2040, NBTX is projected to trade between $142.67 and $697.35, averaging $317.04 — a potential gain of +683% from today's $40.50. That is up +103% on the projected 2035 average. Buyers look set to stay in control over this stretch.
Nanobiotix S.A.'s 2050 outlook centres on $490.33, within a $220.65 to $1,127.75 range. That is up +55% on the projected 2040 average. That marks a +11.1x change versus current levels. Momentum favours further upside here.
Investing $1,000 in NBTX today (≈ 24.691358 NBTX) could be worth
$12,106.86
+$11,106.86 (+1111%) by 2050 · US Dollar
Based on the average projected NBTX price of $490.33 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in NBTXwould be worth at today's price.
$1,000 invested in NBTX on May 27, 2025 (≈ 262.467196 NBTX) would be worth
$10,629.92
+$9,629.92 (+963.0%) today · 10.63× · US Dollar
Based on a NBTX entry price of $3.81 vs. today's $40.5.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $43.16 | $938.37 | -6.2% |
| 1 month ago | $33.11 | $1,223.2 | +22.3% |
| 3 months ago | $27.51 | $1,472.19 | +47.2% |
| 6 months ago | $20.69 | $1,957.47 | +95.7% |
| 1 year ago | $3.81 | $10,629.92 | +963.0% |
| All time (5.0y) ago | $17.39 | $2,328.92 | +132.9% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our NBTX forecast.
Our base-case forecast reaches $81.00 around 2031.
Implied market cap at $81.00: $4.11B
The multi-year forecast shows a bullish trajectory with 2030 an average of $78.41 and a return on investment of 91.2%. The 2040 forecast stands at an average of $313.97 with a 665.6% ROI, and the 2050 forecast sits at an average of $490.76 with a 1096.7% ROI. The 2026 forecast begins at an average of $41.01 with a neutral sentiment, moving higher in subsequent years.
Tap a question to reveal the answer.
2030 average price is $78.41 with a min of $48.18 and a max of $136.77, ROI 91.2% and sentiment BULLISH.
Forecasts show a bullish sentiment from 2027 onward with ROI values such as 2027 35.2%, 2028 38.9%, 2029 50.6%, 2030 91.2%, and 2050 1096.7%. These are estimates and not guarantees.
Yes. The 2026 max forecast is $60.45, and the thirty-day range high is $61.08.
Current price is $41.01 and market cap is $1.99B.
2040 average $313.97 with ROI 665.6% and 2050 average $490.76 with ROI 1096.7%.
Nanobiotix S.A. Community Discussion
0Share your Nanobiotix S.A. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.